This exclusive Pack contains 12 courses: 1. ISO/IEC 17025 Update - The Latest Standard for Laboratory Competence 2. Objectionable Microorganisms in Biopharmaceutical Production - Identification and Risk Mitigation 3. Quality Control for Analytical Materials used in Microbiology Laboratories 4. Steam Sterilization Microbiology and Autoclave Performance Qualification 5. Is it Microbiological Method Verification or Validation, or Just Semantics? 6. Environmental Monitoring Investigation Techniques for Effective Contamination Control 7. Root Cause Analysis (RCA) in the Laboratory - Addressing Non-Conformances 8. Regulatory and Testing Requirements of the Bacterial Endotoxin Testing (BET) or LAL Program 9. Aseptic Process Overview and Validation 10. Ensuring Integrity and Security of Laboratory Data for FDA / EU Compliance 11. Handling OOS Test Results and Completing Robust Investigations 12. Analytical Microbiology - Contract Lab vs In-House Lab - How to Overcome the Corporate Dilemma Total Duration: 15 Hours


$1500 $2700-44.44%
  • Shipping: 

Learn More



TOPIC 1

ISO/IEC 17025 Update - The Latest Standard for Laboratory Competence

TOPIC 2

Objectionable Microorganisms in Biopharmaceutical Production - Identification and Risk Mitigation

Speaker: Michael Brodsky
Duration: 60 Minutes
Speaker: Carl Patterson
Duration: 60 Minutes

Agenda:

  • Definition of Good Clinical Practice
  • Provide a historical perspective on GCP
  • Why do we need GCP?
  • 13 core principles of GCP
  • Introduction to ICH E6
  • Review of ICH E6 (R3) Latest Guidance
  • How to implement GCP in your organization
Agenda:
  • Regulations pertaining to objectionable microorganisms
  • Knowing what microorganisms are considered objectionable
  • The importance of knowing what microorganism are there in your product
  • Identifying objectionable microorganisms
  • Sources of microorganisms in pharmaceutical manufacturing facility
  • How to determine if you have an objectionable microorganism
  • Tests to determine objectionable microorganisms
  • Methods to control and reduce the amount of objectionable microorganisms

TOPIC 3

Quality Control for Analytical Materials Used in Microbiology Laboratories

TOPIC 4

Steam Sterilization Microbiology and Autoclave Performance Qualification

Speaker: Michael Brodsky
Duration: 60 Minutes
Speaker: Danielle DeLucy
Duration: 75 Minutes

Agenda:

  • Control Points
  • Critical Control Points
  • QC from purchase to disposal
  • Performance Criteria
  • Sterility
  • Productivity
  • Selectivity



Agenda:
  • Steam sterilization on a microbial level
  • IQ/OQ/PQ Requirements for Autoclave Validation
  • Regulatory and GMP requirements for steam sterilization
  • Autoclave Monitoring Tests
  • Process verification tools for use in an autoclave
  • Biological Indicators - How and When to Use
  • Common questions, problems and cGMPs
  • Verification vs. Revalidation
TOPIC 5

Is it Microbiological Method Verification or Validation, or Just Semantics?

Speaker: Michael Brodsky
Duration: 60 Minutes
Agenda:
  • Evaluating the difference between Method validation and verification
  • Method validation to establish performance characteristics
  • Method Verification to establish analytical competency
  • Fitness for purpose

TOPIC 6

Environmental Monitoring Investigation Techniques for Effective Contamination Control

Speaker: Carl Patterson
Duration: 60 Minutes
Agenda:
  • International Regulations (ISO)
  • Federal regulation (FDA, USP)
  • Contamination events
  • Non-viable testing
  • Viable testing
  • Use of disinfectants for cleanrooms
  • Possible root causes
  • Identification of microorganisms

TOPIC 7

Root Cause Analysis (RCA) in the Laboratory - Addressing Non-Conformances

Speaker: Michael Brodsky
Duration: 60 Minutes
Agenda:
  • Defining the Problem
  • Examining the Data
  • Identifying Possible Causal Factors
  • Identifying the Root Cause(s)
  • Taking Corrective Action
  • Verifying the effectiveness of the corrective action

TOPIC 8

Regulatory and Testing Requirements of the Bacterial Endotoxin Testing (BET) or LAL Program

Speaker: Carl Patterson
Duration: 60 Minutes
Agenda:
  • Introduction to current USP <85> Bacterial Endotoxin Test
  • Types of Bacterial Endotoxin Test Methodologies
  • Advantages and Disadvantages of Each Methodology and Choosing the Appropriate Method
  • Initiating a Bacterial Endotoxin Test-Initial Considerations
  • LAL Testing Materials and Reagent Qualification
  • Products Receipt, Handling and Storage
  • Product Processing
  • Handling, Investigating and Resolving Failure and Out of Specification (OOS) Results
  • Relationship of Endotoxin Test (LAL) with other Production and Process Controls
TOPIC 9

Aseptic Process Overview and Validation

Speaker: Kelly Thomas
Duration: 90 Minutes
Agenda:
  • Explain the difference between Aseptic and Bulk processing
  • Understand facility and personnel requirements necessary to maintain microbial control
  • Explain basic principles of aseptic processing, including:
  • Cleanliness classifications
  • Process differences between aseptically produced and terminally sterilized product
  • Relation of manufacturing and handling procedures to sources of product contamination
  • Elements of a robust environmental program and why EM is important
  • The role of isolator technology
  • Process Validation Requirements: How to Perform a Successful Media Fill
  • Process Validation Requirements: Sterile Filtration Validation








TOPIC 10

Ensuring Integrity and Security of Laboratory Data for FDA / EU Compliance

Speaker: Dr. Ludwig Huber
Duration: 75 Minutes
Agenda:
  • Eight key FDA/EU requirements for integrity and security of laboratory data.
  • How FDA inspectors check integrity and security of data.
  • Most frequent security and integrity issues: going through recent 483’s, EIRs and warning letters?
  • The importance of limited access to ‘individual users’ rather than to groups.
  • FDA compliant definition, acquisition, maintenance and archiving of raw data.
  • Critical integrity and security issues during the entire life of laboratory data: from data acquisition through evaluation to archiving.
  • Examples how to ensure and document data integrity.
  • Documenting changes of laboratory data: paper, hybrid systems, electronic.
  • The importance of electronic audit trail to document data integrity.
  • Review of electronic audit trail: who, what, when and how.
  • Ensuring timely availability through validated back-up and archiving.
  • Going through representative 10 case studies: FDA observations, complete responses to each observation, corrective actions and preventive actions.
TOPIC 11
TOPIC 12

Handling OOS Test Results and Completing Robust Investigations

Speaker: Danielle DeLucy
Duration: 180 Minutes
Agenda:


Session 1: Guidelines for Detecting an OOS or Atypical Result
  • Definition Atypical or Out of Specification Result?
  • Review of the FDA Guidance for Industry on Investigating OOS Test Results
  • Phase I: Initial Laboratory Investigation
  • Phase II: Full Scale Investigation
  • Root Cause Analysis Methods
  • 5 Whys
  • Flow Charts
  • Checklists
  • Fishbone Diagrams

Session 2: Testing the hypotheses regarding potential root causes

  • Retesting
  • Considering Other Batches

Session 3: Developing a proper CAPA plan to address any Corrective Actions

  • How to properly document findings
  • Example of a proper OOS investigation write up

Analytical Microbiology - Contract Lab vs In-House Lab - How to Overcome the Corporate Dilemma

Speaker: Michael Brodsky
Duration: 60 Minutes
Agenda:

  • Who is doing what
  • Purpose of testing
  • Organisms of concern and risk factors
  • Analytical methods
  • Time constraints
  • Laboratory capabilities and facilities
  • Laboratory accreditation and FSMA
  • Analyst competency
  • Cost considerations



People who bought this also bought